Peter Bronsert
Impact in
- Oncology top 1%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 52
- Pancreatic and Hepatic Oncology Research 30
- Cancer Cells and Metastasis 17
- Co-authors
- Ulrich T. Hopt (21 shared papers)Thomas Brabletz (7 shared papers)Martin Werner (46 shared papers)Ulrich F. Wellner (36 shared papers)Jens Hoeppner (17 shared papers)Tobias Keck (27 shared papers)Marc P. Stemmler (3 shared papers)Simone Brabletz (3 shared papers)
- Journals
- Cancers (10 papers)Scientific Reports (5 papers)International Journal of Molecular Sciences (5 papers)Journal of Cancer (5 papers)Frontiers in Oncology (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Peter Bronsert
137 papers receiving 4.1k citations
Peter Bronsert's Hit Papers
Peers
Comparison fields: 5 of 132
- Oncology 1.5k
- Cancer Research 773
- Pulmonary and Respiratory Medicine 848
- Physiology 97
- Molecular Biology 1.3k
Countries citing papers authored by Peter Bronsert
This map shows the geographic impact of Peter Bronsert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bronsert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bronsert more than expected).
Fields of papers citing papers by Peter Bronsert
This network shows the impact of papers produced by Peter Bronsert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bronsert. The network helps show where Peter Bronsert may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Bronsert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer Hit paper breakdown → | 2017 | 755 |
| 2 | 2016 | 218 | |
| 3 | 2015 | 197 | |
| 4 | 2018 | 154 | |
| 5 | 2016 | 102 | |
| 6 | 2019 | 97 | |
| 7 | 2022 | 95 | |
| 8 | 2019 | 86 | |
| 9 | 2014 | 78 | |
| 10 | 2017 | 77 | |
| 11 | 2015 | 69 | |
| 12 | 2017 | 69 | |
| 13 | 2017 | 68 | |
| 14 | 2022 | 65 | |
| 15 | 2013 | 63 | |
| 16 | 2015 | 60 | |
| 17 | 2017 | 60 | |
| 18 | 2014 | 52 | |
| 19 | 2018 | 51 | |
| 20 | 2018 | 49 |
About Peter Bronsert
Peter Bronsert is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 148 papers that have together received 4.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (30 papers), Cancer Cells and Metastasis (17 papers), Cancer Genomics and Diagnostics (12 papers), Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Sarcoma Diagnosis and Treatment (7 papers) and Esophageal Cancer Research and Treatment (6 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (773 citations), Pulmonary and Respiratory Medicine (848 citations), Physiology (97 citations) and Molecular Biology (1.3k citations). Peter Bronsert has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Ulrich T. Hopt, Thomas Brabletz, Martin Werner, Ulrich F. Wellner, Jens Hoeppner, Tobias Keck, Marc P. Stemmler, Simone Brabletz, Oliver Schilling and Melanie Boerries. Their work appears in journals such as Cancers, Scientific Reports, International Journal of Molecular Sciences, Journal of Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.